APOE and atherosclerosis: On the other hand, FXR deletion in Apo E-knockout or LDLR-knockout mice ameliorates atherosclerosis by reducing plasma LDL levels and decreasing the expression of the scavenger receptor CD36 in macrophages [197,198].